Michael M Ward

Author PubWeight™ 87.91‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007 12.62
2 Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 2011 5.56
3 Patient participation in medical consultations: why some patients are more involved than others. Med Care 2005 3.68
4 Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 2010 3.58
5 Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum 2005 2.76
6 Measuring function in rheumatoid arthritis: Identifying reversible and irreversible components. Arthritis Rheum 2006 2.75
7 The shortened disabilities of the arm, shoulder and hand questionnaire (QuickDASH): validity and reliability based on responses within the full-length DASH. BMC Musculoskelet Disord 2006 2.67
8 The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum 2013 2.40
9 Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. JAMA 2007 2.17
10 Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis. Arthritis Rheum 2013 1.72
11 Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum 2007 1.53
12 Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis 2006 1.47
13 Suicidal ideation among adults with arthritis: prevalence and subgroups at highest risk. Data from the 2007-2008 National Health and Nutrition Examination Survey. Arthritis Care Res (Hoboken) 2011 1.42
14 Changes in the rates of joint surgery among patients with rheumatoid arthritis in California, 1983-2007. Ann Rheum Dis 2009 1.36
15 Ethnic and socioeconomic disparities in health among patients with rheumatic disease. Curr Opin Rheumatol 2005 1.34
16 Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade. Proc Natl Acad Sci U S A 2011 1.33
17 Time perspective and socioeconomic status: a link to socioeconomic disparities in health? Soc Sci Med 2009 1.27
18 Computer aided evaluation of ankylosing spondylitis using high-resolution CT. IEEE Trans Med Imaging 2008 1.19
19 Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study. Arthritis Rheum 2012 1.10
20 Psychological correlates of self-reported functional limitation in patients with ankylosing spondylitis. Arthritis Res Ther 2009 1.08
21 Whole-blood gene expression profiling in ankylosing spondylitis shows upregulation of toll-like receptor 4 and 5. J Rheumatol 2010 1.05
22 Socioeconomic and ethnic differences in disease burden and disparities in physical function in older adults. Am J Public Health 2010 0.99
23 Sleep disturbances in adults with arthritis: prevalence, mediators, and subgroups at greatest risk. Data from the 2007 National Health Interview Survey. Arthritis Care Res (Hoboken) 2011 0.96
24 Estimating rare disease prevalence from administrative hospitalization databases. Epidemiology 2005 0.95
25 Sex disparities in self-reported physical functioning: true differences, reporting bias, or incomplete adjustment for confounding? J Am Geriatr Soc 2010 0.95
26 Quality of care for incident lupus nephritis among Medicaid beneficiaries in the United States. Arthritis Care Res (Hoboken) 2014 0.94
27 Economic considerations of the treatment of ankylosing spondylitis. Am J Med Sci 2012 0.93
28 Psychological correlates of self-reported disease activity in ankylosing spondylitis. J Rheumatol 2010 0.92
29 Quantitative measurement of syndesmophyte volume and height in ankylosing spondylitis using CT. Ann Rheum Dis 2013 0.92
30 The contribution of disease activity on functional limitations over time through psychological mediators: a 12-month longitudinal study in patients with ankylosing spondylitis. Rheumatology (Oxford) 2011 0.91
31 The chromosome 16q region associated with ankylosing spondylitis includes the candidate gene tumour necrosis factor receptor type 1-associated death domain (TRADD). Ann Rheum Dis 2009 0.90
32 Hospitalizations for coronary artery disease among patients with systemic lupus erythematosus. Arthritis Rheum 2003 0.88
33 Cervical vertebral squaring in patients without spondyloarthritis. J Rheumatol 2012 0.88
34 Advances in the treatment of inflammatory arthritis. Best Pract Res Clin Rheumatol 2012 0.87
35 A pilot study of yoga as self-care for arthritis in minority communities. Health Qual Life Outcomes 2013 0.86
36 Improved precision of syndesmophyte measurement for the evaluation of ankylosing spondylitis using CT: a phantom and patient study. Phys Med Biol 2012 0.85
37 Comparison of the construct validity and sensitivity to change of the visual analog scale and a modified rating scale as measures of patient global assessment in rheumatoid arthritis. J Rheumatol 2010 0.85
38 Time perspective and smoking, obesity, and exercise in a community sample. Am J Health Behav 2013 0.84
39 Validity of clinical associations of biomarkers in translational research studies: the case of systemic autoimmune diseases. Arthritis Res Ther 2010 0.83
40 Interpreting studies of cardiovascular mortality in rheumatoid arthritis: the importance of timing. Arthritis Rheum 2008 0.81
41 Validation of new biomarkers in systemic autoimmune diseases. Nat Rev Rheumatol 2011 0.81
42 Ankylosing spondylitis: patterns of radiographic involvement--a re-examination of accepted principles in a cohort of 769 patients. Radiology 2010 0.81
43 Prospects for disease modification in ankylosing spondylitis: do nonsteroidal antiinflammatory drugs do more than treat symptoms? Arthritis Rheum 2005 0.80
44 Association of measured physical performance and demographic and health characteristics with self-reported physical function: implications for the interpretation of self-reported limitations. Health Qual Life Outcomes 2010 0.80
45 Thirty-day hospital readmissions in systemic lupus erythematosus: predictors and hospital- and state-level variation. Arthritis Rheumatol 2014 0.80
46 Rheumatology care, patient expectations, and the limits of time. Arthritis Rheum 2004 0.80
47 Perioperative all-cause mortality and cardiovascular events in patients with rheumatoid arthritis: comparison with unaffected controls and persons with diabetes mellitus. Arthritis Rheum 2012 0.80
48 Is there a higher genetic load of susceptibility loci in familial ankylosing spondylitis? Arthritis Care Res (Hoboken) 2012 0.80
49 Time perspective and exercise, obesity, and smoking: moderation of associations by age. Am J Health Promot 2013 0.79
50 Validation of English and Spanish-language versions of a screening questionnaire for rheumatoid arthritis in an underserved community. J Rheumatol 2008 0.79
51 Measurement and treatment of radiographic progression in ankylosing spondylitis: lessons learned from observational studies and clinical trials. Curr Opin Rheumatol 2014 0.78
52 Medicare reimbursement and the use of biologic agents: incentives, access, the public good, and optimal care. Arthritis Care Res (Hoboken) 2010 0.78
53 Trends in hospitalizations for Pneumocystis jiroveci pneumonia among patients with rheumatoid arthritis in the US: 1996-2007. Arthritis Rheum 2010 0.78
54 Syndesmophyte growth in ankylosing spondylitis. Curr Opin Rheumatol 2015 0.77
55 High precision semi-automated vertebral height measurement using computed tomography: A phantom study. Conf Proc IEEE Eng Med Biol Soc 2012 0.77
56 Ceiling effects and the Schober test. J Rheumatol 2003 0.77
57 Rheumatoid arthritis: Guidelines for the management of RA: breadth versus depth. Nat Rev Rheumatol 2009 0.77
58 Functional limitations due to axial and peripheral joint impairments in patients with ankylosing spondylitis: are focused measures more informative? Arthritis Care Res (Hoboken) 2013 0.77
59 Estimating disease prevalence and incidence using administrative data: some assembly required. J Rheumatol 2013 0.77
60 17 and 23: prime numbers for ankylosing spondylitis? Lancet 2013 0.76
61 Summary of the 2005 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). J Rheumatol 2006 0.76
62 Measures of psychological distress in patients with arthritis: comment on the article by Fuller-Thomson and Shaked. Arthritis Care Res (Hoboken) 2010 0.75
63 Physical therapy and surgery. Am J Med Sci 2012 0.75
64 Precision of syndesmophyte volume measurement for ankylosing spondylitis: a phantom study using high resolution CT. Conf Proc IEEE Eng Med Biol Soc 2009 0.75
65 High precision semiautomated computed tomography measurement of lumbar disk and vertebral heights. Med Phys 2013 0.75
66 Sulfasalazine for the treatment of ankylosing spondylitis: relic or niche medication? Arthritis Rheum 2011 0.75
67 Short-term perioperative all-cause mortality and cardiovascular events in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2013 0.75
68 Linear measurement of polyps in CT colonography using level sets on 3D surfaces. Conf Proc IEEE Eng Med Biol Soc 2009 0.75
69 Autoimmune diseases: early diagnosis and new treatment strategies. Clin Chem 2012 0.75